Eli Lilly has guided its oral GLP-1 drug candidate orforglipron through two more late-phase tests in Type 2 diabetes, racking up wins against placebo and AstraZeneca’s Farxiga to stay on track to seek ...
Though Novo Nordisk had a first-mover advantage in the GLP-1 market, Eli Lilly is catching up. Lilly's recent clinical progress sets it up for another critical approval. The company has fantastic ...
Just as Adverum Biotechnologies' cash reserves were running dry, Eli Lilly has swooped in to buy the biotech and its phase 3-stage eye disease gene therapy. The prize for Lilly is ixo-vec, an ...
Eli Lilly stock (NYSE: LLY) is up 10% this month, a rise driven by strong clinical trial progress. This includes the announcement of positive Phase 3 results in October 2025 for its oral GLP-1 drug, ...
Now four years into a first-in-class FDA approval for certain HR-positive, HER2-negative early breast cancers, Eli Lilly’s Verzenio has proven it can extend patients’ lives in the indication. Verzenio ...
Serena & Lily and Lilly Pulitzer collaborated on a holiday-themed tablescape for a "Dress the Table" event in Palm Beach. The design combined Serena & Lily's calming style with Lilly Pulitzer's ...
Eli Lilly (NYSE:LLY) on Friday reported plans to acquire Adverum Biotechnologies (NASDAQ:ADVM) and its lead gene therapy candidate, Ixo-vec, sending Adverum shares soaring in premarket trading. Under ...
Meghana Keshavan covers biotech and contributes to The Readout newsletter. Get your daily dose of health and medicine every weekday with STAT’s free newsletter Morning Rounds. Sign up here. Morning, ...
Oct 15 (Reuters) - Eli Lilly's (LLY.N), opens new tab experimental weight-loss pill showed superior blood sugar control in diabetic patients across two late-stage trials, the company said on Wednesday ...
Oct 24 (Reuters) - Eli Lilly (LLY.N), opens new tab said on Friday it would acquire gene therapy developer Adverum Biotechnologies (ADVM.O), opens new tab in a deal valued at up to $261.7 million, ...
Join me on a 3-day bushcraft adventure as I search for shelter in deep snow, build a survival camp, and adapt to extreme cold using only basic tools and natural materials. A true test of endurance, ...